Message from the CEO
木村 仁Hitoshi Kimura
Hitoshi Kimura started his career in the pharmaceutical industry at Daiichi Pharmaceutical Co., Ltd. (currently, Daiichi Sankyo Co., Ltd.) as the Area Leader of Integrated Marketing & Sales, International Division, following his experience in the banking industry.
He received a BA in Economics from Keio University in 1998 and an MBA from The University of Texas at Austin, McCombs School of Business, in 2008.
He is currently the President and CEO of CRECON Research & Consulting Inc., CRECON Medical Assessment Inc., Encise Inc., and Medicode Inc., as well as the Chairman and CEO of CRECON Genomics Inc.
Built upon the foundation of CRECON Health Intelligence, we are committed to advancing a sustainable healthcare environment.
Guided by our mission of ‘Contributing to a Sustainable Healthcare Environment,’ CRECON Group delivers comprehensive, customer-tailored solutions to diverse healthcare challenges by leveraging data-driven insights and specialized expertise cultivated in Japan for over 70 years.
CRECON Health Intelligence, represents the driving force behind our commitment to all healthcare stakeholders—from patients and their families to healthcare providers, medical institutions, pharmaceutical wholesalers, pharmaceutical companies, government authorities, payers, and academia.
Over the decades, we have built an extensive track record across various healthcare sectors—conducting market research and consulting, delivering pharmaceutical distribution insights and data, supporting medical procurement and ordering systems. Our expertise also encompasses developing healthcare coding solutions, providing medical economic assessment and policy design support, and offering genomic diagnostic analysis and bioinformatics solutions.
CRECON Health Intelligence represents a multidimensional foundation that integrates proven healthcare expertise—both domestic and global—with regulatory compliance, international standards, robust security governance, and advanced application of evolving AI technologies. Ultimately, it is the driving force behind our commitment to a sustainable healthcare environment. Underpinned by this foundation, we deliver deep insights and prompt solutions to support each of our customers in their decision-making.
Our corporate principles are rooted in ‘Trust, Appreciation, and Contribution.’ Healthcare is a vital social infrastructure centered on patients and sustained by the sincere dedication of countless individuals, including healthcare providers. As we play our part in this essential system, establishing relationships of trust with all stakeholders remains the starting point of everything we do. We view every single inquiry as a valuable insight from daily healthcare practice, and we are dedicated to addressing each one meticulously and sincerely.
Honoring the trust placed in us by delivering high-quality outcomes—this is our way of contributing to the healthcare environment and is a commitment shared by all employees at CRECON Group.
The healthcare landscape is undergoing a major transformation, driven by a series of compounding challenges: a declining birthrate, and aging population; the need to secure healthcare resources amid regional and specialty disparities; the balance between innovative diagnostics and treatments and social security costs; and geopolitical supply chain risks affecting the stable supply of medical products. To overcome these intricate challenges and realize new possibilities brought by technological innovation, multifaceted perspectives and approaches are indispensable.
We, at CRECON Group, are committed to fostering a sustainable healthcare environment by integrating multiple perspectives across technology, clinical practice, manufacturing, distribution, economics, policy, and frontline operations.
CRECON Health Intelligence
木村 仁
Hitoshi Kimura